verified SJR 3,144 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Springer Nature

workspace_premium Q1 — Oncology visibility_off Single blind Peer Review lock_open Open Access Unclaimed

British Journal of Cancer

British Journal of Cancer is a journal indexed in SJR in Oncology and Cancer Research with an H index of 281. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 3580 €. The scope of the journal is focused on Clinical Cancer, Oncology, Radiotherapy, Chemotherapy. It has an SJR impact factor of 3,144 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,144.

British Journal of Cancer focuses its scope in these topics and keywords: cancer, breast, cell, study, lung, patients, tumour, expression, chemotherapy, effects, ...

ISSN: 0007-0920

Editorial: Springer Nature

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Visitar Portal de la Editorial menu_book Guía para Autores (Guidelines)

schedule Datos CoP · solo campos en BD

SJR Impact Factor trending_up

3,144 Q1

H-index 281

Tasa de Aceptación pie_chart

18% Selectiva

Fuente Acceptance_Rate

Tiempo a publicación hourglass_top

NPD

Campo Sin dato

Coste de Publicación (APC) payments

3.580 € Open Access

Ruta Non-OA 0 €

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

3,144

H-index

281

Docs (year)

403

Docs 3y

1332

Total refs

19363

Cites 3y

9854

Citable 3y

1199

Cites/Doc 2y

6.34

Ref/Doc

48.05

Immediate OA

3580 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cancer risk and occupational exposure to aflatoxins in Denmark

Urinary tract infections and reduced risk of bladder cancer in Los Angeles

Deleterious effect of serum proteins on the amphotericin B-induced potentiation of cisplatin in human colon cancer cells

Covariate-adjusted analysis of the Phase 3 REFLECT study of lenvatinib versus sorafenib in the treatment of unresectable hepatocellular carcinoma

Conclusion

Comparison of standard and double reading and computer-aided detection (CAD) of interval cancers at prior negative screening mammograms: blind review

Cognitive behaviour therapy for fatigued cancer survivors: long-term follow-up

Clinical significance of immune cell infiltration within gallbladder cancer

ChlVPP combination chemotherapy for Hodgkin's disease: long term results

Chemotherapy for ovarian cancer: yesterday, today and tomorrow

Characterisation of p53 status at the gene, chromosomal and protein levels in oesophageal adenocarcinoma

Cancers associated with Kaposi's sarcoma (KS) in AIDS: a link between KS herpesvirus and immunoblastic lymphoma

SHOW MORE ARTICLES

Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband

"Concomitant immunity" in murine tumours of non-detectable immunogenicity

Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors

Bladder cancer in cancer patients: population-based estimates from a large Swedish study

Aspirin use and lung cancer in men

Approaches to improving breast screening uptake: evidence and experience from Tower Hamlets

Antibodies against lytic and latent Kaposi's sarcoma-associated herpes virus antigens and lymphoma in the European EpiLymph case-control study

Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer

Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy

A visual summary of the EUROCARE-4 results: a UK perspective

A recombinant single chain antibody interleukin-2 fusion protein

A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro

FAQS

In Country of Papers you can find SJR impact factor and other metrics to help you decide on a Journal.